RJA
ACHV icon

Raymond James & Associates’s Achieve Life Sciences ACHV Stock Holding History

Raymond James & Associates’s Portfolio ACHV Stock Details ACHV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$679K Sell
143,328
-7,121
-5% -$32.5K ﹤0.01% 2926
2024
Q2 		$707K Sell
150,449
-1,400
-0.9% -$6.75K ﹤0.01% 2852
2024
Q1 		$690K Sell
151,849
-2,980
-2% -$13.2K ﹤0.01% 2856
2023
Q4 		$638K Buy
154,829
+8,729
+6% +$38K ﹤0.01% 2805
2023
Q3 		$628K Buy
146,100
+8,615
+6% +$43.4K ﹤0.01% 2744
2023
Q2 		$714K Buy
137,485
+33,203
+32% +$233K ﹤0.01% 2693
2023
Q1 		$709K Buy
104,282
+15,033
+17% +$71.4K ﹤0.01% 2688
2022
Q4 		$219K Buy
89,249
+71,818
+412% +$184K ﹤0.01% 3404
2022
Q3 		$58K Buy
17,431
+4,482
+35% +$21.4K ﹤0.01% 3689
2022
Q2 		$63K Sell
12,949
-165
-1% -$1.12K ﹤0.01% 3758
2022
Q1 		$99K Buy
+13,114
New +$97.7K ﹤0.01% 3822

Other funds holding ACHV

Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
PBM
Propel Bio Management Los Angeles, California $159M AUM 60.94% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2B AUM 117.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $1.6B AUM 121.58% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.3B AUM 33.54% 1-Year Est. Return
SC
Shay Capital New York $704M AUM 37.47% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return